Inhibrx Invested Capital Average Trend from 2010 to 2022

INBX -  USA Stock  

USD 24.61  1.41  6.08%

Inhibrx Invested Capital Average yearly trend continues to be fairly stable with very little volatility. Invested Capital Average will likely drop to about 31 M in 2022. During the period from 2010 to 2022, Inhibrx Invested Capital Average regression line of anual values had slope of 1,018,246 and arithmetic mean of  21,466,873. Income Tax Expense is likely to rise to 2,771 in 2022, whereas Consolidated Income is likely to drop (73.9 M) in 2022.

Inhibrx Historical Trends 

 
Refresh
Check Inhibrx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx main balance sheet or income statement drivers, such as Gross Profit of 14.5 M, Interest Expense of 10 M or Net Income to Non Controlling Interests of 127.1 K, as well as many exotic indicators such as Asset Turnover of 0.14, Book Value per Share of 3.71 or Current Ratio of 5.22. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Valuation or Volatility modules. It can also supplement various Inhibrx Technical models. Please see the analysis of Inhibrx Correlation against competitors.

Inhibrx Invested Capital Average Breakdown

Showing smoothed Invested Capital Average of Inhibrx with missing and latest data points interpolated. Average invested capital value for the period used in the calculation of [ROIC]; and derived from [InvCap]. Invested capital is an input into the calculation of [ROIC]; and is calculated as: Total Debt plus Total Assets minus [Intangibles] minus Cash and Equivalents minus Current Liabilities. Please note this calculation method is subject to change.Inhibrx's Invested Capital Average historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inhibrx's overall financial position and show how it may be relating to other accounts over time.
Invested Capital Average10 Years Trend
Increasing
Slightly volatile
 Invested Capital Average 
Share
      Timeline 

Inhibrx Invested Capital Average Regression Statistics

Arithmetic Mean 21,466,873
Geometric Mean 20,940,859
Coefficient Of Variation 25.25
Mean Deviation 4,329,804
Median 18,652,500
Standard Deviation 5,419,750
Range 14,262,225
R-Value 0.73
R-Squared 0.54
Significance 0.004473
Slope 1,018,246

Inhibrx Invested Capital Average History

202028.6 M
202132.9 M
202231 M

About Inhibrx Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Inhibrx income statement, its balance sheet, and the statement of cash flows. Inhibrx investors use historical funamental indicators, such as Inhibrx's Invested Capital Average, to determine how well the company is positioned to perform in the future. Although Inhibrx investors may use each financial statement separately, they are all related. The changes in Inhibrx's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Inhibrx's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Inhibrx Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Inhibrx. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Invested Capital24.3 M24.1 M
Invested Capital Average32.9 M31 M
Market Capitalization1.1 B1.1 B
Working Capital115.9 M125 M
Average Assets97.9 M81.4 M
Average Equity-10.4 M-11.2 M
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. Inhibrx, Inc. was founded in 2010 and is headquartered in La Jolla, California. Inhibrx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 84 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Inhibrx without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pattern Recognition Now

   

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Inhibrx using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see the analysis of Inhibrx Correlation against competitors. Note that the Inhibrx information on this page should be used as a complementary analysis to other Inhibrx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Inhibrx Stock analysis

When running Inhibrx price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Is Inhibrx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inhibrx. If investors know Inhibrx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inhibrx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Inhibrx is measured differently than its book value, which is the value of Inhibrx that is recorded on the company's balance sheet. Investors also form their own opinion of Inhibrx's value that differs from its market value or its book value, called intrinsic value, which is Inhibrx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inhibrx's market value can be influenced by many factors that don't directly affect Inhibrx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inhibrx's value and its price as these two are different measures arrived at by different means. Investors typically determine Inhibrx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inhibrx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.